Oxford BioDynamics (OBD) News Today GBX 0.49 -0.02 (-4.31%) As of 02/13/2025 11:29 AM Eastern Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsHeadlinesInsider Trades All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 Time Period Oxford BioDynamics inks distribution deal with Romanian medical firmFebruary 12 at 2:31 PM | lse.co.ukOxford BioDynamics enters Romanian market with Regina MariaFebruary 12 at 2:31 PM | msn.comOxford BioDynamics, Plc: Oxford BioDynamics' EpiSwitch CRC Blood Test Accurately Detects both Cancer and PolypsFebruary 5, 2025 | finanznachrichten.deAIM WINNERS & LOSERS: Arrow Exploration well disappointsFebruary 5, 2025 | lse.co.ukOxford BioDynamics’ EpiSwitch® CRC Blood Test Accurately Detects both Cancer and PolypsFebruary 5, 2025 | finance.yahoo.comOxford BioDynamics' test shows high accuracy for CRC detectionFebruary 5, 2025 | msn.comOxford BioDynamics confirms new shares and director appointmentsJanuary 31, 2025 | msn.comOxford BioDynamics Secures Loan to Extend Financial RunwayDecember 20, 2024 | markets.businessinsider.comOxford BioDynamics explores funding amid share fluctuationDecember 6, 2024 | uk.investing.comOxford BioDynamics Issues Shares to Preserve CashOctober 29, 2024 | markets.businessinsider.comInsider Buying: Oxford BioDynamics Plc (LON:OBD) Insider Acquires 49,653 Shares of StockOctober 29, 2024 | insidertrades.comOxford BioDynamics Unveils Promising COVID Severity TestOctober 25, 2024 | markets.businessinsider.comLONDON MARKET CLOSE: Stocks climb as PM says UK is open for businessOctober 14, 2024 | lse.co.ukOxford BioDynamics pledges to cut costs amid need to raise extra fundsOctober 14, 2024 | lse.co.ukNew Oxford trucking company pleads to Clean Air Act violation - disabled emissions monitorSeptember 27, 2024 | yahoo.comTheracryf Plc (TCF.L) Stock Price, News, Quote & History - Yahoo FinanceSeptember 23, 2024 | finance.yahoo.comWhere To Dine In Oxford For A Special OccasionMarch 14, 2024 | msn.comOxford Biodynamics PLC (OBD)March 13, 2024 | uk.investing.comOxford researchers develop early detection test for Parkinson'sDecember 10, 2023 | msn.comOxford BioDynamics PLC OBDNovember 3, 2023 | morningstar.comBupa UK to cover EpiSwitch® CiRT for customers with cancerOctober 18, 2023 | finance.yahoo.comMARKET REPORT: Shares in prostate test firm more than doubleSeptember 26, 2023 | msn.comSeveral Insiders Invested In Oxford BioDynamics Flagging Positive NewsSeptember 4, 2023 | finance.yahoo.comOxford BioDynamics proposes GBP7 million fundraise for EpiSwitch plansAugust 1, 2023 | lse.co.ukOBD.L - Oxford BioDynamics PlcJuly 18, 2023 | uk.finance.yahoo.comOxford BioDynamics Shares Fall on Wider 1H Loss, Need for More CashMay 30, 2023 | marketwatch.comOxford BioDynamics Receives $963,000 Award for Adverse Response Oncology TestMay 2, 2023 | marketwatch.comThis blood test can detect prostate cancer with 94 percent accuracyFebruary 10, 2023 | msn.comScientists create ‘impressive’ new blood test for prostate cancer that is 94% accurateFebruary 8, 2023 | msn.comNew blood test for prostate cancer is 94% accurate, researchers sayFebruary 7, 2023 | msn.comThe Non-Executive Director of Oxford BioDynamics Plc (LON:OBD), Stephen Diggle, Just Bought A Few More SharesFebruary 2, 2023 | finance.yahoo.comOxford BioDynamics Full Year 2022 Earnings: UK£0.067 loss per share (vs UK£0.072 loss in FY 2021)January 29, 2023 | finance.yahoo.comOxford BioDynamics in San Francisco for the 41st Annual J.P. Morgan Healthcare ConferenceDecember 19, 2022 | finance.yahoo.comMassachusetts General Hospital Reports Results of Interim Analysis from REFINE-ALS Biomarker Trial by Mitsubishi Tanabe Pharma USA, Utilizing Oxford Biodynamics’ EpiSwitch® Platform for Prognostic Stratification of Fast Progression ALSDecember 16, 2022 | finance.yahoo.comOxford BioDynamicsOctober 8, 2022 | fool.co.ukOxford BioDynamics (LON:OBD) Will Have To Spend Its Cash WiselyOctober 8, 2022 | finance.yahoo.comOxford BioDynamics to Raise Up to GBP12 Mln to Boost Cancer Test CommercializationOctober 7, 2022 | marketwatch.comOxford BioDynamics shares drop as it might need funding by early 2023June 28, 2022 | lse.co.ukOxford BioDynamics's Checkpoint Inhibitor Response Test (EpiSwitch(R) CiRT) Now Available in the UKJune 21, 2022 | barrons.comOxford BioDynamics Plc (OBD.L)March 11, 2022 | finance.yahoo.comIs Oxford BioDynamics (LON:OBD) In A Good Position To Deliver On Growth Plans?November 22, 2021 | finance.yahoo.comArmistice Capital Invests GBP3.6 Mln in Oxford BioDynamicsOctober 25, 2021 | marketwatch.comGeronimo the alpaca euthanised in Britain despite public outcryAugust 31, 2021 | lse.co.ukTRADING UPDATES: Jet2 in bumper Airbus order; Strix China factory liveAugust 31, 2021 | lse.co.ukRyanair predicts strong recovery, ups passenger targetAugust 31, 2021 | lse.co.ukOxford BioDynamics awarded $0.91m US PACT grantAugust 31, 2021 | lse.co.ukOxford BioDynamics Awarded US FNIH Grant to Apply EpiSwitch® Immune Health Test for Improved Prediction of Patient Response to Immune Checkpoint Inhibitor (ICI) Cancer TherapiesAugust 31, 2021 | finance.yahoo.comGenetic Testing Market is projected to manifest the fastest CAGR of 11.53% through 2027July 29, 2021 | marketwatch.comPioneering blood test which tells Covid patients how severe their illness will be and gives a result in 15 minutes is approved for sale to UK hospitalsJuly 27, 2021 | dailymail.co.uk Get Oxford BioDynamics News Delivered to You Automatically Sign up to receive the latest news and ratings for OBD and its competitors with MarketBeat's FREE daily newsletter. Email Address OBD Media Mentions By Week OBD Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. OBD News Sentiment▼0.200.39▲Average Medical News Sentiment OBD News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. OBD Articles This Week▼20▲OBD Articles Average Week Get Oxford BioDynamics News Delivered to You Automatically Sign up to receive the latest news and ratings for OBD and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies IXI News Today SNG News Today BSFA News Today DEST News Today PYC News Today VAL News Today HEMO News Today ONT News Today GNS News Today OXB News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (LON:OBD) was last updated on 2/14/2025 by MarketBeat.com Staff From Our Partners*Breaking News!* This Pharma NASDAQ Company and the U.S Army!!! This Little Known NASDAQ Company just released positive results from its drugs that have been undergoing testi...Trading Wire | SponsoredCentral Bank Abandons USDWarren Buffett Dumping Stocks at Record Levels… Discover how savvy Americans are positioning their retireme...True Gold Republic | Sponsored My 2025 AI BlueprintI first recommended Bitcoin at $300 in 2013 … before it went up 33,645%. Now, I am revealing my 2025 AI Blu...Weiss Ratings | SponsoredGrab This Altcoin Before Trump's Crypto AnnouncementGrab This Altcoin Before Trump's Crypto Announcement Whatever it is, I expect it to pump the market, which ...Crypto 101 Media | SponsoredWe recommended Palantir in 2021, now we’re recommending this...I believe it could offer you a MAJOR boost to your retirement. And it pays huge dividends to give you a nic...Behind the Markets | SponsoredJUST RELEASED: HUGE NEW A.I. TRADEI’ve traded every major tech boom since the dawn of the personal computer. And I can tell you one thing wit...The Oxford Club | SponsoredSecret financial plot unfolding in Washington DC… [DEVELOPING]What stocks are next up to soar in 2025? I believe I’ve found the answer - and it might surprise you. Yo...Timothy Sykes | Sponsored[RFK Jr CONFIRMED] But Will THIS Be His DownfallRobert F. Kennedy Jr was just confirmed as Trump’s secretary of Health and Human Services… but it was NOT easy...NewMarket Health Publishing, LLC. | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Oxford BioDynamics Plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Oxford BioDynamics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.